Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Julie M. Plyler

Associate

New York +1 212 841 1090

  • About
  • Representative Matters
  • Credentials
  • About

    Julie Plyler is a member of the firm’s Corporate Practice Group, with an emphasis on capital markets and securities transactions, corporate governance, and SEC reporting matters. Julie regularly represents issuers, underwriters and institutional investors in connection with private and public equity and debt financings. She also represents companies in connection with M&A and financing transactions.

    Areas of Expertise

  • Practices and Industries
  • Representative Matters
    • Advised Banca Intesa Sanpaolo on U.S. law aspects of its tender offer for, and subsequent acquisition of, UBI Banca.
    • Advised Humacyte, Inc. in its $800 million deSPAC merger with Alpha Healthcare Acquisition Corp.
    • Advised REGENXBIO Inc. in a $230.3 million public offering of common stock.
    • Advised Omeros Corporation in a $210 million convertible notes offering and $100 million common stock offering.
    • Advised Insmed Incorporated in a public offering of $575 million of convertible senior notes and public offerings of over $540 million of common stock.
    • Advised TriState Capital Holdings in various capital markets offerings, including $121 million of depositary share offerings, $97.5 million of subordinated debt offerings and a $105 million private placement.
    • Advised the underwriters in the initial public offerings of Trevi Therapeutics, Inc. and Nightstar Therapeutics plc.

    • Advised the underwriters in a global offering of ordinary shares and ADSs of ERYTECH Pharma S.A.
    • Advised the underwriters in various follow-on offerings, including those of UroGen Pharma Ltd., Corbus Pharmaceuticals Holdings, Inc., RedHill BioPharma Ltd. and Nabriva Therapeutics plc.
    • Advised the sales agent in various at-the-market offerings, including those of Corbus Pharmaceuticals Holdings, Inc., Celldex Therapeutics, Inc. and Nabriva Therapeutics plc.
    • Advised Johnson & Johnson in its sale of RoC Skincare.
    • Advised SK Holdings in its acquisition of a significant minority interest in Eureka Midstream.
    • Advises public companies on Exchange Act periodic reporting, proxy statements, Section 16 reporting and securities compliance matters.

    Areas of Expertise

  • Credentials
    Education
    • University of Virginia School of Law, J.D., 2016
        • Virginia Law and Business Review, Senior Review Editor
    • University of Florida, M.P.H., 2012
    • Duke University, B.A., 2009
    Bar Admissions
    • New York
    Pro Bono
    • Provides legal services and advice to the Jackie Robinson Foundation, a national, not-for-profit organization committed to perpetuating the memory of Jackie Robinson by promoting civic engagement and humanitarian ideals as well as addressing the achievement gap in higher education, in connection with the development of the Jackie Robinson Museum.

    Areas of Expertise

News and Insights

Events